Want to join the conversation?
$ABC said it cut its FY16 adjusted EPS outlook to $5.44 to $5.54 from prior expectations of $5.73 to $5.83 due to an increase in the rate of generic deflation, and a lower contribution from new generic launches. The company preliminarily expects FY2017 adjusted EPS growth to in the range of 4% to 6%.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?